Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin

European Journal of Clinical Pharmacology
W MückJ Kuhlmann

Abstract

Cerivastatin is a novel, synthetic, highly potent 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor that effectively reduces serum cholesterol levels at very low doses. It is exclusively cleared from humans via cytochrome P450-mediated biotransformation (demethylation M1; hydroxylation M23) and subsequent biliary/renal excretion of the metabolites. The influence of concomitant administration of erythromycin, a potent CYP3A4 inhibitor, on cerivastatin bioavailability and pharmacokinetics was investigated. Twelve healthy young male subjects received single oral doses of 300 microg cerivastatin alone or on the 4th day of a 4-day pre- and co-treatment with erythromycin 500 mg t.i.d. in a randomised, non-blind crossover study. Plasma and urine samples were analysed for cerivastatin and its major metabolites by validated specific high-performance liquid chromatography assays. Cerivastatin was safe and well tolerated. No clinically relevant treatment-emergent changes in laboratory parameters were observed. The pre- and co-treatment with erythromycin 500 mg t.i.d. had a modest influence on cerivastatin clearance, leading to a mean increase in the maximum plasma concentration (Cmax) of 13% and a slightly increased term...Continue Reading

Citations

Oct 5, 2001·The American Journal of Medicine·P H ChongC Franklin
Sep 28, 2001·International Journal of Antimicrobial Agents·E Rubinstein
Jul 15, 1998·British Journal of Clinical Pharmacology·W MückG Ahr
Sep 8, 2000·Clinical Pharmacokinetics·W Mück
May 31, 2002·Clinical Pharmacokinetics·David Williams, John Feely
Mar 22, 2001·British Journal of Clinical Pharmacology·L ZivianiL E Iavarone
Aug 16, 2006·Expert Opinion on Drug Safety·Atul TiwariKasim Mookhtiar
Nov 4, 2000·Expert Opinion on Investigational Drugs·M J Tikkanen
Aug 9, 2003·Expert Opinion on Drug Safety·Michael H Davidson
Jun 11, 2015·Expert Opinion on Drug Metabolism & Toxicology·Takeshi Hirota, Ichiro Ieiri
May 9, 2002·Drug Metabolism Reviews·Slobodan Rendic
Jan 2, 2016·Pharmacological Reviews·Janne T BackmanPertti J Neuvonen
Nov 17, 2009·Annales Françaises D'anesthèsie Et De Rèanimation·N LibertL Brinquin
Jul 15, 2015·Pharmaceutical Research·Manthena V VarmaAyman F El-Kattan
Feb 27, 2013·Journal of Clinical Pharmacy and Therapeutics·J Juřica, A Žourková
Sep 16, 1998·The American Journal of Cardiology·H Bischoff, A H Heller
Sep 16, 1998·The American Journal of Cardiology·D B Hunninghake
Apr 20, 2000·The Annals of Pharmacotherapy·M P PaiG W Amsden
Nov 19, 2009·The Annals of Pharmacotherapy·James M BackesPatrick M Moriarty
Jul 6, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·M UcarR Dahlqvist
Jul 26, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Marc Evans, Alan Rees
Oct 29, 2004·Drug Metabolism and Drug Interactions·David F V LewisMaurice Dickins
Jan 23, 2003·The Journal of Pharmacology and Experimental Therapeutics·Yoshihisa ShitaraYuichi Sugiyama
Nov 16, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jun-Sheng WangPertti J Neuvonen
Oct 14, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Aleksandra GaletinJ Brian Houston
Jun 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Martin KondžaIvan Ćavar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Clinical Pharmacology
T KantolaP J Neuvonen
Journal of Emergency Nursing : JEN : Official Publication of the Emergency Department Nurses Association
Juli Havens-Verkler, Anne Marie Lewis
© 2022 Meta ULC. All rights reserved